Results 21 to 30 of about 157,438 (357)
Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis [PDF]
The Korean Journal of Internal Medicine, 2021 Background/Aims Inhibitors of the renin-angiotensin system, angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), reportedly have anti-inflammatory effects.
Hyun Woo Lee +3 more
doaj +1 more source
ACE-inhibition prevents postischemic coronary leukocyte adhesion and leukocyte-dependent reperfusion injury [PDF]
, 1997 Objective: Polymorphonuclear leukocytes (PMN), retained in the microvascular bed, can contribute to postischemic myocardial reperfusion injury. Since a beneficial effect of ACE-inhibition on reperfusion injury has been reported, we investigated the ...
Becker, Bernhard F. +6 more
core +1 more source
Kidney & Blood Pressure Research, 2013 Background: Treating non-diabetic proteinuric patients with advanced renal disease with an angiotensin-converting enzyme (ACE) inhibitor is still subject to discussion.
Charles Christian Adarkwah +3 more
doaj +1 more source
British Journal of Clinical Pharmacology, 2002 Edited by P. D’Orlèans‐Juste & G. E. Plante Published by Birkhauser [Milestones in drug therapy series] 187 pages, price @116, ISBN 3‐7643‐5982 ...
D. J. Webb, N. F. Kelland
openaire +2 more sources
Circulation, 1998 To the Editor: In a recent issue of Circulation , Brown and Vaughan1 reviewed ACE inhibitors. They stated that captopril and lisinopril are active drugs and listed 7 other ACE inhibitors approved in the United States that are inactive prodrugs until metabolized in the liver.
openaire +2 more sources
Aliskiren, enalapril, or aliskiren and enalapril in heart failure [PDF]
, 2016 BACKGROUND Among patients with chronic heart failure, angiotensin-converting–enzyme (ACE) inhibitors reduce mortality and hospitalization, but the role of a renin inhibitor in such patients is unknown.
] +15 more
core +5 more sources
Dose response of ACE inhibitors: implications of the SECURE trial
Current Controlled Trials in Cardiovascular Medicine, 2001 The choice of the appropriate dosage of ACE inhibitor in clinical practice is an important one. The available evidence suggests that in chronic heart failure as well as in chronic coronary artery disease, high doses of angiotensin-converting enzyme (ACE)
Lonn Eva
doaj +1 more source
Effect of angiotensin‐converting enzyme inhibition on cardiovascular adaptation to exercise training
Physiological Reports, 2022 Angiotensin‐converting enzyme (ACE) activity may be one determinant of adaptability to exercise training, but well‐controlled studies in humans without confounding conditions are lacking.
Tórur Sjúrðarson +13 more
doaj +1 more source
Angioedema after local trauma in a patient on angiotensin-converting enzyme inhibitor therapy [PDF]
, 2008 Angioedema is a side effect that is often associated with use of angiotensin converting enzyme inhibitor medications. These medications result in increased levels of circulating bradykinins.
Bryden, L.eslie A. +3 more
core +2 more sources
Cardiovascular Drugs and Therapy, 1993 There are chemical differences among angiotensin-converting enzyme (ACE) inhibitors that profoundly influence the pharmacokinetics and dynamics of different drugs. Differences in potency, affinity, and duration of action can be readily identified.
openaire +6 more sources